Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Oncology R&D Pipeline

Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Programs 5,539

Quick answer

Oncology: NovaPharmaNews indexes 5,539 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Top sponsors

Pipeline programs

Page 87 of 116

  1. Arm 1 cemiplimab

    Regeneron UK Limited

    Hepatocellular Carcinoma

    phase 1 small molecule active

    1 trial

  2. Arsenic trioxide

    Teva Pharma GmbH

    Chronic Myelogenous Leukemia

    phase 1 small molecule terminated

    1 trial

  3. Atezolizumab

    Hoffmann-La Roche

    Advanced Ovarian Cancer

    phase 1 small molecule terminated

    1 trial

  4. Atezolizumab

    Jazz Pharmaceuticals Ireland Limited

    Endometrial Cancer

    phase 1 small molecule active

    1 trial

  5. Atovaquone Oral Suspension

    United Therapeutics Europe Ltd

    Locally Advanced Non-Small Cell Lung Cancer

    phase 1 small molecule completed

    1 trial

  6. Atu027

    Silence Therapeutics plc

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  7. Autologous Natural Killer Cell Therapy

    Hospital Authority, Hong Kong

    Hepatocellular Carcinoma

    phase 1 small molecule active

    1 trial

  8. Autologous tumor-infiltrating lymphocyte cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced Solid Tumor

    phase 1 mab terminated

    1 trial

  9. Autologous γδT cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-Hodgkin's Lymphoma

    phase 1 mab active

    1 trial

  10. Axatilimab

    Syndax Pharmaceuticals

    Solid Tumor

    phase 1 small molecule completed

    1 trial

  11. Azenosertib

    Zentalis Pharmaceuticals

    Solid Tumor

    phase 1 small molecule active

    2 trials

  12. Azenosertib

    Zentalis Pharmaceuticals

    Osteosarcoma

    phase 1 small molecule completed

    1 trial

  13. BAY2965501

    Bayer HealthCare AG

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  14. BBO-10203

    BridgeBio Oncology Therapeutics

    Solid Tumor, Adult

    phase 1 small molecule active

    1 trial

  15. BBO-11818

    BridgeBio Oncology Therapeutics

    Non-Small Cell Lung Cancer

    phase 1 small molecule active

    1 trial

  16. BBO-8520

    BridgeBio Oncology Therapeutics

    Non-small Cell Lung Cancer

    phase 1 small molecule active

    1 trial

  17. BBP-398

    BridgeBio Oncology Therapeutics

    Solid Tumor, Adult

    phase 1 small molecule terminated

    1 trial

  18. BBP-398 (Formerly known as IACS-15509)

    BridgeBio Oncology Therapeutics

    Tumor, Solid

    phase 1 small molecule terminated

    1 trial

  19. BBP-398 with nivolumab

    BridgeBio Oncology Therapeutics

    Non Small Cell Lung Cancer

    phase 1 small molecule terminated

    1 trial

  20. BC006

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced Solid Tumors (Including GCTTS)

    phase 1 small molecule active

    1 trial

  21. BCA-81472709

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer

    phase 1 small molecule active

    1 trial

  22. BCA101

    Bicara Therapeutics

    Head and Neck Squamous Cell Carcinoma

    phase 1 small molecule active

    1 trial

  23. BCSW-LDP+CDP1-Ⅰ-01

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced Malignant Tumor

    phase 1 small molecule active

    1 trial

  24. BDB001 (EIK1001)

    Eikon Therapeutics

    Tumor, Solid

    phase 1 small molecule completed

    2 trials

  25. BDB018

    Eikon Therapeutics

    Tumor, Solid

    phase 1 small molecule completed

    1 trial

  26. BDC-3042

    Bolt Biotherapeutics

    Triple Negative Breast Cancer

    phase 1 small molecule terminated

    1 trial

  27. BDTX-189

    Blackmores Limited

    Solid Tumor

    phase 1 small molecule terminated

    1 trial

  28. BEL-X-HG

    Taiwan Liposome Company

    Advanced Solid Tumors

    phase 1 small molecule terminated

    1 trial

  29. BET-PSMA-001

    Blue Earth Diagnostics Ireland Ltd

    PSMA-positive non-curative metastatic castration-resistant prostate cancer

    phase 1 small molecule active

    1 trial

  30. BEZ235 + MEK162

    Pfizer

    Unspecified Adult Solid Tumor, Protocol Specific

    phase 1 small molecule completed

    1 trial

  31. BG-60366

    BEONE MEDICINES AUS PTY LTD

    Non-Small Cell Lung Cancer

    phase 1 small molecule terminated

    1 trial

  32. BG-60366-101

    BEONE MEDICINES AUS PTY LTD

    EGFR-Mutant Non-Small Cell Lung Cancer

    phase 1 other active

    1 trial

  33. BG-68501

    BEONE MEDICINES AUS PTY LTD

    Breast Cancer

    phase 1 small molecule active

    1 trial

  34. BG-75098

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  35. BG-75202

    BEONE MEDICINES AUS PTY LTD

    Breast Cancer

    phase 1 small molecule active

    1 trial

  36. BG-75202-101

    BEONE MEDICINES AUS PTY LTD

    Advanced and Metastatic Solid tumors

    phase 1 other active

    1 trial

  37. BG-89894

    BEONE MEDICINES AUS PTY LTD

    Advanced or Metastatic MTAP-deleted Solid Tumors

    phase 1 small molecule terminated

    1 trial

  38. BG-C0902

    BEONE MEDICINES AUS PTY LTD

    Solid Tumors

    phase 1 small molecule active

    1 trial

  39. BG-C0979

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  40. BG-C0979-101

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumors

    phase 1 other active

    1 trial

  41. BG-C137

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  42. BG-C477

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  43. BG-C9074

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  44. BGB-15025

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  45. BGB-21447

    BEONE MEDICINES AUS PTY LTD

    Hormone-receptor-positive Breast Cancer

    phase 1 small molecule active

    1 trial

  46. BGB-21447

    BEONE MEDICINES AUS PTY LTD

    Relapsed Non-Hodgkin Lymphoma

    phase 1 small molecule active

    1 trial

  47. BGB-24714

    BEONE MEDICINES AUS PTY LTD

    Solid Tumor, Adult

    phase 1 small molecule terminated

    1 trial

  48. BGB-26808

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many oncology pipeline programs are tracked?

5,539 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.